Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Big Pharma Sees a Market in Psychedelic Drugs Again – Thanks to Vaccine Skeptic Kennedy

Summary by NRC Handelsblad
For a long time, the development of psychedelics like LSD and psilocybin was reserved for small start-ups. The multi-billion dollar acquisition of Atai Beckley by pharmaceutical giant Eli Lilly shows that the industry has high expectations for these substances – partly thanks to vaccine skeptic Robert F. Kennedy in the Trump administration.

1 Articles

NRC HandelsbladNRC Handelsblad
Lean Left

Big Pharma Sees a Market in Psychedelic Drugs Again – Thanks to Vaccine Skeptic Kennedy

For a long time, the development of psychedelics like LSD and psilocybin was reserved for small start-ups. The multi-billion dollar acquisition of Atai Beckley by pharmaceutical giant Eli Lilly shows that the industry has high expectations for these substances – partly thanks to vaccine skeptic Robert F. Kennedy in the Trump administration.

·Amsterdam, Netherlands (Kingdom of the)
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

NRC Handelsblad broke the news in Amsterdam, Netherlands (Kingdom of the) on Wednesday, October 14, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Psychedelics icon

Psychedelics

Netherlands icon

Netherlands

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal